Task Force 2: Clinical Considerations for the Pre-Participation Cardiac Evaluation of Competitive Athletes

Sudden cardiac arrest (SCA) is the leading cause of sudden death during sports and exercise. Pre-participation cardiac screening is one component of the comprehensive pre-participation evaluation (PPE), aiming to identify previously unrecognized cardiovascular conditions that may increase the risk of SCA/D during sports participation. It warrants careful planning to maximize efficacy and minimize potential harms, including exacerbating health disparities. Core elements of the PPE include a focused history & physical (H&P) and the 12-lead electrocardiogram conducted by well-trained clinicians, with readily accessible expert consultation for secondary evaluation when necessary. As no primary prevention screening approach provides absolute protection against SCA, a well-developed emergency action plan is an essential part of comprehensive cardiovascular care for athletes of all levels.

Authors

Institutions

Publication Details

Journal
Medicine & Science in Sports & Exercise
Published
2026-11-13
DOI
https://doi.org/10.1249/mss.0000000000004090
Primary Topic
Cardiovascular Effects of Exercise
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Task Force 2: Clinical Considerations for the Pre-Participation Cardiac Evaluation of Competitive Athletes

Antonio Pelliccia, Dermot M.J. Phelan, Jonathan A. Drezner, Sheela Krishnan et al.
1 links
Medicine & Science in Sports & Exercise
Cardiovascular Effects of Exercise
article

Task Force 2: Clinical Considerations for the Pre-Participation Cardiac Evaluation of Competitive Athletes

Antonio Pelliccia, Dermot M.J. Phelan, Jonathan A. Drezner, Sheela Krishnan, Jonathan H. Kim, Guido Claessen, Aaron Leigh Baggish, Michael Papadakis, BENJAMIN D. LEVINE, SANJAY SHARMA
article en

Abstract

Sudden cardiac arrest (SCA) is the leading cause of sudden death during sports and exercise. Pre-participation cardiac screening is one component of the comprehensive pre-participation evaluation (PPE), aiming to identify previously unrecognized cardiovascular conditions that may increase the risk of SCA/D during sports participation. It warrants careful planning to maximize efficacy and minimize potential harms, including exacerbating health disparities. Core elements of the PPE include a focused history & physical (H&P) and the 12-lead electrocardiogram conducted by well-trained clinicians, with readily accessible expert consultation for secondary evaluation when necessary. As no primary prevention screening approach provides absolute protection against SCA, a well-developed emergency action plan is an essential part of comprehensive cardiovascular care for athletes of all levels.

Medicine & Science in Sports & ExerciseVol. 58(12)
National Health Service (GB), Emory University (US), St George's, University of London (GB), University of Washington (US), Texas Health Dallas (US), St George’s University Hospitals NHS Foundation Trust (GB), Centre Hospitalier Universitaire Vaudois (CH), Massachusetts General Hospital (US), Jessa Hospital (BE), MaineHealth (US), Maine Medical Center (US), Hartcentrum Hasselt (BE), Institute for Exercise and Environmental Medicine (US), Cleveland Clinic London (GB), The University of Texas Southwestern Medical Center (US), Hasselt University (BE), KU Leuven (BE)
Good health and well-being
Cardiovascular Effects of Exercise
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon